KMT2D and esophageal squamous cell carcinoma: Although KMT2D can act as a tumor suppressor in some cancers, such as medulloblastoma or bladder cancer, in esophageal squamous cell carcinoma cells, KMT2D knockout inhibited cell proliferation and migration and reduced epithelial-mesenchymal transition [26,101,102].